Nutrient-sensitizing drug repurposing screen identifies lomerizine as a mitochondrial metabolism inhibitor of chronic myeloid leukemia.
Khalaf A, de Beauchamp L, Kalkman E, Rattigan K, Himonas E, Jones J, James D, Shokry ESA, Scott MT, Dunn K, Tardito S, Copland M, Sumpton D, Shanks E, Helgason GV.
Khalaf A, et al. Among authors: scott mt.
Sci Transl Med. 2024 Jun 12;16(751):eadi5336. doi: 10.1126/scitranslmed.adi5336. Epub 2024 Jun 12.
Sci Transl Med. 2024.
PMID: 38865484